108 related articles for article (PubMed ID: 14069382)
1. TOTAL HYSTERECTOMY COMBINED WITH PROPHYLACTIC BILATERAL OOPHORECTOMY IN TREATMENT OF BREAST CANCER.
VARDEN LC; RICHTMEYER DC
Va Med Mon (1918); 1963 Oct; 90():501-4. PubMed ID: 14069382
[No Abstract] [Full Text] [Related]
2. Prophylactic versus therapeutic oophorectomy in stage 1 and 2 breast cancer in Utah.
Matolo N; Smart CR
Rocky Mt Med J; 1970 Oct; 67(10):39-42. PubMed ID: 5472052
[No Abstract] [Full Text] [Related]
3. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Rebbeck TR; Friebel T; Lynch HT; Neuhausen SL; van 't Veer L; Garber JE; Evans GR; Narod SA; Isaacs C; Matloff E; Daly MB; Olopade OI; Weber BL
J Clin Oncol; 2004 Mar; 22(6):1055-62. PubMed ID: 14981104
[TBL] [Abstract][Full Text] [Related]
4. [Prophylactic radiological and surgical castration in cancer of the breast].
Marini G; Pistocchi F
Nunt Radiol; 1968 Jul; 34(7):659-66. PubMed ID: 5736513
[No Abstract] [Full Text] [Related]
5. Acceptance for preventive genetic testing and prophylactic surgery in women with a family history of breast and gynaecological cancers.
Ackermann S; Lux MP; Fasching PA; Strissl P; Renner SP; Poehls U; Bender HG; Beckmann MW
Eur J Cancer Prev; 2006 Dec; 15(6):474-9. PubMed ID: 17106324
[TBL] [Abstract][Full Text] [Related]
6. Laparoscopic oophorectomy in the management of breast disease.
Willsher P; Ali A; Jackson L
ANZ J Surg; 2008 Aug; 78(8):670-2. PubMed ID: 18796025
[TBL] [Abstract][Full Text] [Related]
7. [Breast neoplasms. Result of combined treatment: extended Halstead operation with and without bilateral oophorectomy in one stage].
POLETTO E; AUDENINO RG
Dia Med; 1961 Jul; 33():1275-7. PubMed ID: 13736715
[No Abstract] [Full Text] [Related]
8. [Bilateral breast cancer and pregnancy].
Giordano C; Damba A; Ciari Júnior C
Matern Infanc (Sao Paulo); 1965; 24(4):575-92. PubMed ID: 5889100
[No Abstract] [Full Text] [Related]
9. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
10. A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices.
Geiger AM; Yu O; Herrinton LJ; Barlow WE; Harris EL; Rolnick S; Barton MB; Elmore JG; Fletcher SW
Arch Intern Med; 2005 Mar; 165(5):516-20. PubMed ID: 15767526
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.
Schmeler KM; Sun CC; Bodurka DC; White KG; Soliman PT; Uyei AR; Erlichman JL; Arun BK; Daniels MS; Rimes SA; Peterson SK; Slomovitz BM; Milam MR; Gershenson DM; Lu KH
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):515-20. PubMed ID: 16946209
[TBL] [Abstract][Full Text] [Related]
12. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA;
J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327
[TBL] [Abstract][Full Text] [Related]
13. Metastasis of breast cancer to a uterine leiomyoma.
Kondo NI; Yoshida S; Kajiyama H; Nagasaka T; Uematsu T
Breast Cancer; 2009; 16(2):157-61. PubMed ID: 18751874
[TBL] [Abstract][Full Text] [Related]
14. Quality of life after bilateral prophylactic mastectomy.
Geiger AM; Nekhlyudov L; Herrinton LJ; Rolnick SJ; Greene SM; West CN; Harris EL; Elmore JG; Altschuler A; Liu IL; Fletcher SW; Emmons KM
Ann Surg Oncol; 2007 Feb; 14(2):686-94. PubMed ID: 17103066
[TBL] [Abstract][Full Text] [Related]
15. THERAPEUTIC CASTRATION VERSUS PROPHYLACTIC CASTRATION IN BREAST CANCER.
KENNEDY BJ; MIELKE PW; FORTUNY IE
Surg Gynecol Obstet; 1964 Mar; 118():524-40. PubMed ID: 14133086
[No Abstract] [Full Text] [Related]
16. Prophylactic oophorectomy in women at increased cancer risk.
Domchek SM; Rebbeck TR
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):27-30. PubMed ID: 17218848
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer and artificial menopause: a cohort study.
Feinleib M
J Natl Cancer Inst; 1968 Aug; 41(2):315-29. PubMed ID: 5671283
[No Abstract] [Full Text] [Related]
18. Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer.
Meiser B; Butow P; Price M; Bennett B; Berry G; Tucker K;
J Womens Health (Larchmt); 2003 Oct; 12(8):769-78. PubMed ID: 14588127
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic bilateral salpingo-oophorectomy (PBSO) with or without prophylactic bilateral mastectomy (PBM) or no intervention in BRCA1 mutation carriers: a cost-effectiveness analysis.
Norum J; Hagen AI; Maehle L; Apold J; Burn J; Møller P
Eur J Cancer; 2008 May; 44(7):963-71. PubMed ID: 18362067
[TBL] [Abstract][Full Text] [Related]
20. Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction.
Isern AE; Tengrup I; Loman N; Olsson H; Ringberg A
J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1177-87. PubMed ID: 17938010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
